Literature DB >> 25671623

As Ebola epidemic begins to slow, trials of drugs and vaccines speed up.

Bridget M Kuehn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25671623     DOI： 10.1001/jama.2015.0942

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  From bench to almost bedside: the long road to a licensed Ebola virus vaccine.

Authors:  Gary Wong; Emelissa J Mendoza; Francis A Plummer; George F Gao; Gary P Kobinger; Xiangguo Qiu
Journal:  Expert Opin Biol Ther       Date:  2017-11-17       Impact factor: 4.388

Review 2.  Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.

Authors:  Everardo González-González; Mario Moisés Alvarez; Alan Roberto Márquez-Ipiña; Grissel Trujillo-de Santiago; Luis Mario Rodríguez-Martínez; Nasim Annabi; Ali Khademhosseini
Journal:  Crit Rev Biotechnol       Date:  2015-11-26       Impact factor: 8.429

3.  Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.

Authors:  Sarah A Kessans; Mark D Linhart; Lydia R Meador; Jacquelyn Kilbourne; Brenda G Hogue; Petra Fromme; Nobuyuki Matoba; Tsafrir S Mor
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.